why choose us

First received: June 04, 2023

Clinical Trial: DP303c in Patients With HER2-positive Advanced Breast Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: HER2-positive Advanced Breast Cancer

Study Type: INTERVENTIONAL


Official Title: A Multicentre, Randomized, Open-label, Controlled Phase ? Clinical Study to Evaluate the Efficacy and Safety of DP303cversus Trastuzumab Combined With Vinorelbine/Capecitabine in of HER2-positive

Brief Summary: This is a study of DP303c in patients with HER2-positive advanced breast cancer.

Read more